257 related articles for article (PubMed ID: 26270885)
1. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells.
Sayroo R; Nolasco D; Yin Z; Colon-Cortes Y; Pandya M; Ling C; Aslanidi G
Gene Ther; 2016 Jan; 23(1):18-25. PubMed ID: 26270885
[TBL] [Abstract][Full Text] [Related]
2. High-efficiency transduction of primary human hematopoietic stem cells and erythroid lineage-restricted expression by optimized AAV6 serotype vectors in vitro and in a murine xenograft model in vivo.
Song L; Li X; Jayandharan GR; Wang Y; Aslanidi GV; Ling C; Zhong L; Gao G; Yoder MC; Ling C; Tan M; Srivastava A
PLoS One; 2013; 8(3):e58757. PubMed ID: 23516552
[TBL] [Abstract][Full Text] [Related]
3. Reprogramming Immune Response With Capsid-Optimized AAV6 Vectors for Immunotherapy of Cancer.
Pandya M; Britt K; Hoffman B; Ling C; Aslanidi GV
J Immunother; 2015 Sep; 38(7):292-8. PubMed ID: 26261893
[TBL] [Abstract][Full Text] [Related]
4. Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy.
Pandya J; Ortiz L; Ling C; Rivers AE; Aslanidi G
Immunol Cell Biol; 2014 Feb; 92(2):116-23. PubMed ID: 24217810
[TBL] [Abstract][Full Text] [Related]
5. RGD inclusion in VP3 provides adeno-associated virus type 2 (AAV2)-based vectors with a heparan sulfate-independent cell entry mechanism.
Shi W; Bartlett JS
Mol Ther; 2003 Apr; 7(4):515-25. PubMed ID: 12727115
[TBL] [Abstract][Full Text] [Related]
6. High-Efficiency Transduction of Primary Human Hematopoietic Stem/Progenitor Cells by AAV6 Vectors: Strategies for Overcoming Donor-Variation and Implications in Genome Editing.
Ling C; Bhukhai K; Yin Z; Tan M; Yoder MC; Leboulch P; Payen E; Srivastava A
Sci Rep; 2016 Oct; 6():35495. PubMed ID: 27759036
[TBL] [Abstract][Full Text] [Related]
7. Single amino acid changes can influence titer, heparin binding, and tissue tropism in different adeno-associated virus serotypes.
Wu Z; Asokan A; Grieger JC; Govindasamy L; Agbandje-McKenna M; Samulski RJ
J Virol; 2006 Nov; 80(22):11393-7. PubMed ID: 16943302
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Adeno-Associated Virus 1 and 6 Sialic Acid Binding Site.
Huang LY; Patel A; Ng R; Miller EB; Halder S; McKenna R; Asokan A; Agbandje-McKenna M
J Virol; 2016 Jun; 90(11):5219-5230. PubMed ID: 26962225
[TBL] [Abstract][Full Text] [Related]
9. Optimizing the transduction efficiency of capsid-modified AAV6 serotype vectors in primary human hematopoietic stem cells in vitro and in a xenograft mouse model in vivo.
Song L; Kauss MA; Kopin E; Chandra M; Ul-Hasan T; Miller E; Jayandharan GR; Rivers AE; Aslanidi GV; Ling C; Li B; Ma W; Li X; Andino LM; Zhong L; Tarantal AF; Yoder MC; Wong KK; Tan M; Chatterjee S; Srivastava A
Cytotherapy; 2013 Aug; 15(8):986-98. PubMed ID: 23830234
[TBL] [Abstract][Full Text] [Related]
10. Enhanced transduction efficiency of fiber-substituted adenovirus vectors by the incorporation of RGD peptides in two distinct regions of the adenovirus serotype 35 fiber knob.
Matsui H; Sakurai F; Katayama K; Kurachi S; Tashiro K; Sugio K; Kawabata K; Mizuguchi H
Virus Res; 2011 Jan; 155(1):48-54. PubMed ID: 20801174
[TBL] [Abstract][Full Text] [Related]
11. Development of Optimized AAV Serotype Vectors for High-Efficiency Transduction at Further Reduced Doses.
Ling C; Li B; Ma W; Srivastava A
Hum Gene Ther Methods; 2016 Aug; 27(4):143-9. PubMed ID: 27431826
[TBL] [Abstract][Full Text] [Related]
12. Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by AAV2, But Not AAV8, Vectors in Murine Hepatocytes In Vivo.
Li B; Ma W; Ling C; Van Vliet K; Huang LY; Agbandje-McKenna M; Srivastava A; Aslanidi GV
Hum Gene Ther Methods; 2015 Dec; 26(6):211-20. PubMed ID: 26421998
[TBL] [Abstract][Full Text] [Related]
13. Insertional mutagenesis at positions 520 and 584 of adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors with eliminated heparin- binding ability and introduced novel tropism.
Shi X; Fang G; Shi W; Bartlett JS
Hum Gene Ther; 2006 Mar; 17(3):353-61. PubMed ID: 16544984
[TBL] [Abstract][Full Text] [Related]
14. Engineering adeno-associated virus serotype 2-based targeting vectors using a new insertion site-position 453-and single point mutations.
Boucas J; Lux K; Huber A; Schievenbusch S; von Freyend MJ; Perabo L; Quadt-Humme S; Odenthal M; Hallek M; Büning H
J Gene Med; 2009 Dec; 11(12):1103-13. PubMed ID: 19777441
[TBL] [Abstract][Full Text] [Related]
15. Selection and evaluation of clinically relevant AAV variants in a xenograft liver model.
Lisowski L; Dane AP; Chu K; Zhang Y; Cunningham SC; Wilson EM; Nygaard S; Grompe M; Alexander IE; Kay MA
Nature; 2014 Feb; 506(7488):382-6. PubMed ID: 24390344
[TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus serotype 6 capsid tyrosine-to-phenylalanine mutations improve gene transfer to skeletal muscle.
Qiao C; Zhang W; Yuan Z; Shin JH; Li J; Jayandharan GR; Zhong L; Srivastava A; Xiao X; Duan D
Hum Gene Ther; 2010 Oct; 21(10):1343-8. PubMed ID: 20497037
[TBL] [Abstract][Full Text] [Related]
17. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors.
Halbert CL; Allen JM; Miller AD
J Virol; 2001 Jul; 75(14):6615-24. PubMed ID: 11413329
[TBL] [Abstract][Full Text] [Related]
18. Impact of capsid modifications by selected peptide ligands on recombinant adeno-associated virus serotype 2-mediated gene transduction.
Naumer M; Popa-Wagner R; Kleinschmidt JA
J Gen Virol; 2012 Oct; 93(Pt 10):2131-2141. PubMed ID: 22764318
[TBL] [Abstract][Full Text] [Related]
19. Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell-surface receptors.
Shi W; Arnold GS; Bartlett JS
Hum Gene Ther; 2001 Sep; 12(14):1697-711. PubMed ID: 11560765
[TBL] [Abstract][Full Text] [Related]
20. Optimization of the capsid of recombinant adeno-associated virus 2 (AAV2) vectors: the final threshold?
Aslanidi GV; Rivers AE; Ortiz L; Song L; Ling C; Govindasamy L; Van Vliet K; Tan M; Agbandje-McKenna M; Srivastava A
PLoS One; 2013; 8(3):e59142. PubMed ID: 23527116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
